Cargando…
PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
BACKGROUND: Children exposed to gestational diabetes mellitus (GDM) are at a higher risk of developing obesity and type 2 diabetes. This susceptibility might involve brown adipose tissue (BAT), which is suspected to protect against obesity. The objective of this study is to assess whether fetal expo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918074/ https://www.ncbi.nlm.nih.gov/pubmed/27340502 http://dx.doi.org/10.1186/s13148-016-0239-9 |
_version_ | 1782439053977714688 |
---|---|
author | Côté, Sandra Gagné-Ouellet, Valérie Guay, Simon-Pierre Allard, Catherine Houde, Andrée-Anne Perron, Patrice Baillargeon, Jean-Patrice Gaudet, Daniel Guérin, Renée Brisson, Diane Hivert, Marie-France Bouchard, Luigi |
author_facet | Côté, Sandra Gagné-Ouellet, Valérie Guay, Simon-Pierre Allard, Catherine Houde, Andrée-Anne Perron, Patrice Baillargeon, Jean-Patrice Gaudet, Daniel Guérin, Renée Brisson, Diane Hivert, Marie-France Bouchard, Luigi |
author_sort | Côté, Sandra |
collection | PubMed |
description | BACKGROUND: Children exposed to gestational diabetes mellitus (GDM) are at a higher risk of developing obesity and type 2 diabetes. This susceptibility might involve brown adipose tissue (BAT), which is suspected to protect against obesity. The objective of this study is to assess whether fetal exposure to maternal hyperglycemia is associated with DNA methylation variations in genes involved in BAT genesis and activation. METHODS: DNA methylation levels at the PRDM16, BMP7, CTBP2, and PPARGC1α gene loci were measured in placenta samples using bisulfite pyrosequencing in E-21 (n = 133; 33 cases of GDM) and the HumanMethylation450 array in Gen3G (n = 172, all from non-diabetic women) birth cohorts. Glucose tolerance was assessed in all women using an oral glucose tolerance test at the second trimester of pregnancy. Participating women were extensively phenotyped throughout pregnancy, and placenta and cord blood samples were collected at birth. RESULTS: We report that maternal glycemia at the second and third trimester of pregnancy are correlated with variations in DNA methylation levels at PRDM16, BMP7, and PPARGC1α and with cord blood leptin levels. Variations in PRDM16 and PPARGC1α DNA methylation levels were also correlated with cord blood leptin levels. Mediation analyses support that DNA methylation variations at the PPARGC1α gene locus explain 0.8 % of the cord blood leptin levels variance independently of maternal fasting glucose levels (p = 0.05). CONCLUSIONS: These results suggest that maternal glucose in pregnancy could produce variations in DNA methylation in BAT-related genes and that some of these DNA methylation marks seem to mediate the impact of maternal glycemia on cord blood leptin levels, an adipokine regulating body weight. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0239-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4918074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49180742016-06-24 PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns Côté, Sandra Gagné-Ouellet, Valérie Guay, Simon-Pierre Allard, Catherine Houde, Andrée-Anne Perron, Patrice Baillargeon, Jean-Patrice Gaudet, Daniel Guérin, Renée Brisson, Diane Hivert, Marie-France Bouchard, Luigi Clin Epigenetics Research BACKGROUND: Children exposed to gestational diabetes mellitus (GDM) are at a higher risk of developing obesity and type 2 diabetes. This susceptibility might involve brown adipose tissue (BAT), which is suspected to protect against obesity. The objective of this study is to assess whether fetal exposure to maternal hyperglycemia is associated with DNA methylation variations in genes involved in BAT genesis and activation. METHODS: DNA methylation levels at the PRDM16, BMP7, CTBP2, and PPARGC1α gene loci were measured in placenta samples using bisulfite pyrosequencing in E-21 (n = 133; 33 cases of GDM) and the HumanMethylation450 array in Gen3G (n = 172, all from non-diabetic women) birth cohorts. Glucose tolerance was assessed in all women using an oral glucose tolerance test at the second trimester of pregnancy. Participating women were extensively phenotyped throughout pregnancy, and placenta and cord blood samples were collected at birth. RESULTS: We report that maternal glycemia at the second and third trimester of pregnancy are correlated with variations in DNA methylation levels at PRDM16, BMP7, and PPARGC1α and with cord blood leptin levels. Variations in PRDM16 and PPARGC1α DNA methylation levels were also correlated with cord blood leptin levels. Mediation analyses support that DNA methylation variations at the PPARGC1α gene locus explain 0.8 % of the cord blood leptin levels variance independently of maternal fasting glucose levels (p = 0.05). CONCLUSIONS: These results suggest that maternal glucose in pregnancy could produce variations in DNA methylation in BAT-related genes and that some of these DNA methylation marks seem to mediate the impact of maternal glycemia on cord blood leptin levels, an adipokine regulating body weight. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0239-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-22 /pmc/articles/PMC4918074/ /pubmed/27340502 http://dx.doi.org/10.1186/s13148-016-0239-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Côté, Sandra Gagné-Ouellet, Valérie Guay, Simon-Pierre Allard, Catherine Houde, Andrée-Anne Perron, Patrice Baillargeon, Jean-Patrice Gaudet, Daniel Guérin, Renée Brisson, Diane Hivert, Marie-France Bouchard, Luigi PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
title | PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
title_full | PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
title_fullStr | PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
title_full_unstemmed | PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
title_short | PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
title_sort | ppargc1α gene dna methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918074/ https://www.ncbi.nlm.nih.gov/pubmed/27340502 http://dx.doi.org/10.1186/s13148-016-0239-9 |
work_keys_str_mv | AT cotesandra ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT gagneouelletvalerie ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT guaysimonpierre ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT allardcatherine ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT houdeandreeanne ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT perronpatrice ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT baillargeonjeanpatrice ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT gaudetdaniel ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT guerinrenee ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT brissondiane ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT hivertmariefrance ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns AT bouchardluigi ppargc1agenednamethylationvariationsinhumanplacentamediatethelinkbetweenmaternalhyperglycemiaandleptinlevelsinnewborns |